Patients with rheumatoid arthritis have better functional and working ability but poorer general health and higher comorbidity rates today than in the late 1990s

References

• Scott DL, Smith C, Kingsley G. What are the consequences of early rheumatoid arthritis for the individual. Best Pract Res Clin Rheumatol 2005;19:117–36.
   PubMed Web of Science ®Google Scholar
• Verstappen SMM, Symmons PM. What is the outcome of RA and can we predict it? Best Pract Res Clin Rheumatol 2011;25:485–96.
   PubMed Web of Science ®Google Scholar
• Sokka T. Increases in use of methotrexate since the 1980s. Clin Exp Rheumatol 2010;28(Suppl 61);13–20.
   Google Scholar
• Korpela M, Laasonen L, Hannonen P, Kautiainen H, Leirisalo-Repo M, Hakala M, et al. Retardation of joint damage with early rheumatoid arthritis by initial aggressive treatment with disease-modifying anti-rheumatic drugs: five-year experience from the FIN-RACo study. Arthritis Rheum 2004;50:2072–81.
   PubMed Web of Science ®Google Scholar
• O’Dell JR, Leff R, Paulsen G, Haire C, Mallek J, Eckhoff PJ, et al. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications. Results of a two-year, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2002;46;1164–70.
   PubMed Web of Science ®Google Scholar
• Jurgens MS, Jacobs JWG, Bijlsma JWJ. The use of conventional disease-modifying anti-rheumatic drugs in established RA. Best Pract Res Clin Rheumatol 2011:25;523–33.
   PubMedGoogle Scholar
• Smolen JS, Landewé R, Breedveld FC, Buch M, Burmester G, Dougados M, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying anti-rheumatic drugs: 2013 update. Ann Rheum Dis. Published online: 25 October 2013. doi: 10.1136/annrheumdis-2013-204573.
   Google Scholar
• Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004;364:263–9.
   PubMed Web of Science ®Google Scholar
• Rantalaiho VM, Kautiainen H, Järvenpää S, Virta L, Pohjolainen T, Korpela M, et al. Decline in work disability caused by early rheumatoid arthritis: results from a nationwide Finnish register, 2000–8. Ann Rheum Dis 2013;72:672–8.
   PubMed Web of Science ®Google Scholar
• Strand V, Singh J. Improved health-related quality of life with effective disease modifying anti-rheumatic drugs: evidence from randomized controlled trials. Am J Manag Care 2007;13(Suppl 9):237–50.
   PubMed Web of Science ®Google Scholar
• Kievit W, Fransen J, de Waal Malefijt MC, den Broeder AA, van Reil PL. Treatment changes and improved outcomes in RA: an overview of a large inception cohort from 1989 to 2009. Rheumatology (Oxford) 2013;52:1500–8.
   PubMed Web of Science ®Google Scholar
• Pincus T, Sokka T, Kautiainen H. Patients seen for standard rheumatoid arthritis care have significantly better articular, radiographic, laboratory, and functional status in 2000 than in 1985. Arthritis Rheum 2005;52:1009–19.
   PubMed Web of Science ®Google Scholar
• Ziegler S, Huscher D, Karberg K, Krause A, Wassenberg S, Zink A. Trends in treatment and outcomes of rheumatoid arthritis in Germany 1997–2007: results from the National Database of the German Collaborative Arthritis Centre. Ann Rheum Dis 2010;69:1803–8.
   PubMed Web of Science ®Google Scholar
• Krishnan E, Lingala B, Bruce B, Fries J. Disability in rheumatoid arthritis in the era of biological treatments. Ann Rheum Dis 2012;71:213–18.
   PubMed Web of Science ®Google Scholar
• Baldini C, Sedie AD, Bombardieri S. From clinical trials to the bedside: how can we treat patients with rheumatoid arthritis and concurrent morbidities who are generally excluded from randomised controlled clinical trials? Clin Exp Rheumatol 2005;23:893–904.
   PubMed Web of Science ®Google Scholar
• Tiippana-Kinnunen T, Kautianen H, Paimela L, Leirisalo-Repo M. Comorbidities in Finnish patients with rheumatoid arthritis: 15-year follow-up. Scand J Rheumatol 2013;42:451–6.
   PubMed Web of Science ®Google Scholar
• Radner H, Smolen JS, Aletaha D. Comorbidities affects all domains of physical function and quality of life in patients with rheumatoid arthritis. Rheumatology (Oxford) 2011;50:381–8.
   PubMed Web of Science ®Google Scholar
• Jylhä M. What is self-rated health and why does it predict mortality? Towards a unified conceptual model. Soc Sci Med 2009;69:307–16.
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24.
   PubMed Web of Science ®Google Scholar
• Prevoo ML, van ‘t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44–8.
   PubMed Web of Science ®Google Scholar
• Fransen J, Creemers CW, Van Riel LCM. Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary criteria. Rheumatology (Oxford) 2004;43:1252–5.
   PubMed Web of Science ®Google Scholar
• Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn 1977;17:481–91.
   Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987;40:373–83.
   PubMedGoogle Scholar
• de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity: a critical review of available methods. J Clin Epidemiol 2003;56:221–9.
   PubMed Web of Science ®Google Scholar
• Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994;47:1245–51.
   PubMed Web of Science ®Google Scholar
• Hunt SM, McEwen J, McKenna SP. Measuring health status. London: Croom Helm, 1986.
   Google Scholar
• Hakala M, Nieminen P, Manelius J. Joint impairment is strongly correlated with disability measured by self-reported questionnaires. Functional status assessment of individuals with rheumatoid arthritis in a population based series. J Rheumatol 1994;21:64–9.
   PubMed Web of Science ®Google Scholar
• Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcomes in arthritis. Arthritis Rheum 1980;23:137–45.
   PubMed Web of Science ®Google Scholar
• Lundberg O, Manderbacka K. Assessing reliability of a measure of self-rated health. Scand J Soc Med 1996;24:218–24.
   PubMedGoogle Scholar
• Sany J, Bourgeois P, Saraux A, Durieux S, Lafuma A, Daurès JP, et al. Characteristics of patients with rheumatoid arthritis in France: a study of 1109 patients managed by hospital rheumatologists. Ann Rheum Dis 2004;63:1235–40.
   PubMed Web of Science ®Google Scholar
• Sokka T, Krishnan E, Häkkinen A, Hannonen P. Functional disability in rheumatoid arthritis patients compared with a community population in Finland. Arthritis Rheum 2003;48:59–63.
   PubMed Web of Science ®Google Scholar
• Schmajuk G, Solomon DH, Yazdany J. Patterns of disease-modifying drug use in rheumatoid arthritis patients after 2002: a systematic review. Arthritis Care Res (Hoboken) 2013;65:1927–35.
   Google Scholar
• Sokka T, Haugeberg G, Asikainen J, Widding Hansen IJ, Kokko A, Rannio T, et al. Similar clinical outcomes in rheumatoid arthritis with more versus less expensive treatment strategies. Observational data from two rheumatology clinics. Clin Exp Rheumatol 2013;31:409–14.
   PubMed Web of Science ®Google Scholar
• Rantalaiho V, Kautiainen H, Virta L, Korpela M, Möttönen T, Puolakka K. Trends in treatment strategies and the usage of different disease-modifying anti-rheumatic drugs in early rheumatoid arthritis in Finland. Results from a nationwide register in 2000–2007. Scand J Rheumatol 2011;40:16–21.
   PubMed Web of Science ®Google Scholar
• Rantalaiho V, Korpela M, Hannonen P, Kautiainen H, Järvenpää S, Leirisalo-Repo M, et al. The good initial response to therapy with a combination of traditional disease-modifying anti-rheumatic drugs is sustained over time. The eleven-year results of the Finnish Rheumatoid Arthritis Combination Therapy Trial. Arthritis Rheum 2009;60:1222–31.
   PubMed Web of Science ®Google Scholar
• Jämsen E, Virta LJ, Hakala M, Kauppi MJ, Malmivaara A, Lehto MU. The decline in joint replacement surgery in rheumatoid arthritis is associated with a concomitant increase in the intensity of anti-rheumatic therapy. Acta Orthop 2013:84:331–7.
   PubMed Web of Science ®Google Scholar
• Young A, Wilkinson P, Talamo J, Dixey N, Cox P, Davies J, et al. Socioeconomic deprivation and rheumatoid disease: what lessons for the health service? ERAS Study Group. Early Rheumatoid Arthritis Study. Ann Rheum Dis 2000;59:794–9.
   Google Scholar
• Aromaa A, Huttunen J, Koskinen S, Teperi J, editors. Health in Finland [in Finnish]. Suomalaisten terveys Duodecim: Helsinki, 2005;444–65.
   Google Scholar
• Lacaille D, Sheps S, Spinelli JJ, Chalmers A, Esdaile JM. Identification of modifiable work-related factors that influence the risk of work disability in rheumatoid arthritis. Arthritis Rheum 2004;51:843–52.
   PubMedGoogle Scholar
• Khan NA, Spencer HJ, Abda EA, Alten R, Pohl C, Ancuta C, et al. Patient’s global assessment of disease activity and patient’s assessment of general health for rheumatoid arthritis activity assessment: are they equivalent? Ann Rheum Dis 2012;71:1942–9.
   PubMed Web of Science ®Google Scholar
• Sanderson T, Morris M, Calnan M, Richards P, Hewlett S. Patient perspective of measuring treatment efficacy: the rheumatoid arthritis patient priorities for pharmacological interventions (RAPP-PI) outcomes. Arthritis Care Res (Hoboken) 2010;62:647–56.
   PubMed Web of Science ®Google Scholar
• Scott DL, Pugner K, Kaarela K, Doyle DV, Woolf A, Holmes J, et al. The link between joint damage and disability in rheumatoid arthritis. Rheumatology (Oxford) 2000;39:122–32.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Zwillich SH. The long-term outcomes of rheumatoid arthritis: a 23-year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumatoid arthritis. Arthritis Rheum 1998;41;1072–82.
   PubMed Web of Science ®Google Scholar
• Hakala M, Hannonen P, Helve T, Korpela M, Mattila K, Möttönen T, et al. Rheumatoid arthritis (updated Current Care guideline) [in Finnish (abstract in English)]. Duodecim 2009;125:2131–2.
   PubMedGoogle Scholar
• Björk M, Trupin L, Thyberg I, Katz P, Yelin E. Differences in activity limitation, pain intensity, and global health in patients with rheumatoid arthritis in Sweden and the USA: a 5-year follow-up. Scand J Rheumatol 2011;40:428–43.
   PubMed Web of Science ®Google Scholar